Silvercrest Asset Management Group LLC Artivion, Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.6 Billion
- Q2 2025
A detailed history of Silvercrest Asset Management Group LLC transactions in Artivion, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 756,780 shares of AORT stock, worth $29.9 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
756,780
Previous 481,241
57.26%
Holding current value
$29.9 Million
Previous $11.8 Million
98.98%
% of portfolio
0.16%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding AORT
# of Institutions
193Shares Held
40.2MCall Options Held
19.2KPut Options Held
0-
Black Rock Inc. New York, NY6.64MShares$263 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.96MShares$117 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$111 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$111 Million3.82% of portfolio
-
Morgan Stanley New York, NY2.32MShares$91.7 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.59B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...